Filed with the SEC on · accession 0001104659-26-125188
NXTC filed a 8-K (current report) with the SEC on Nov 10, 2026. NextCure, Inc. furnished an 8-K announcing its financial results for the quarter ended September 30, 2026, via an attached press release. The stock moved -4.6% by the first close after the filing.
NextCure, Inc. furnished an 8-K announcing its financial results for the quarter ended September 30, 2026, via an attached press release. The filing is a routine earnings disclosure under Item 2.02.
Close before
$6.27
Nov 9, 2026
First close after
-4.63%
$5.98
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for NXTC, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for NXTC?
Click hereNXTC filed a 8-K (SEC filing). NextCure, Inc. furnished an 8-K announcing its financial results for the quarter ended September 30, 2026, via an attached press release. The filing is a routine earnings disclosure under Item 2.02.
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
NXTC closed at $6.27 before the filing and $5.98 on Nov 10, 2026 (-4.63%).
Get alerts when NXTC files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days